There will be a Molecular Basis of Leukemogenesis Seminar on Monday, November 17 at 12:00pm in the Goldman International Conference Center of the Feinstein Institute for Medical Research.
The guest speaker will be Carlo M. Croce, MD, distinguished university professor, the John W. Wolfe Chair in Human Cancer Genetics, director of the Institute of Genetics, and director of the Human Cancer Genetics Program at the Ohio State University. Dr. Croce will be presenting “Causes and consequences of microRNA dysregulation in cancer”. Dr. Klein will be hosted by Drs. Kanti Rai and Nicholas Chiorazzi.
Program Objectives: Upon completion of this session, participants should be able to:
- Identify new developments in understanding mechanisms of disease.
- Integrate new investigational results with current diagnostic and treatment protocols.
- Judge the potential importance for current best practices of treatment regimes based on new translational studies.
Target Audience: Researchers, Students, Hospital-based physicians, Housestaff, Nurses, and Community physicians.
CME ACCREDITATION: North Shore-LIJ Health System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT: The North Shore-LIJ Health System designates this live activity for a maximum of 1 AMA PRA Category 1 Credit. Each physician should only claim credit commensurate with the extent of their participation in the activity.
DISCLOSURE POLICY: North Shore-LIJ Health System adheres to the ACCME’s New Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners and managers, are required to disclose all financial relationships with commercial interests. All identified potential conflicts of interest are thoroughly vetted by North Shore-LIJ for fair balance and scientific objectivity and to ensure appropriateness of patient care recommendations.
Planner and Speaker’s Disclosures:
Carlo M. Croce MD has no financial relationships to disclose.
Thomas L. Rothstein, MD, PhD has no financial relationships to disclose.
Bettie Steinberg, PhD receives a drug study grant from Pfizer for being principal investigator.
Recognition of Program Support: An announcement of program support will be made to all attendees at the beginning of each Regularly Scheduled Session.
The post Molecular Basis of Leukemogenesis Seminar appeared first on The Feinstein Institute for Medical Research.